Mostly Biotech 🧬 retweetledi
Mostly Biotech 🧬
10.3K posts

Mostly Biotech 🧬
@n_hatami
🐏 🐑🐑🐑🐑 Not following the herd 🦬
Amsterdam Katılım Mayıs 2017
226 Takip Edilen669 Takipçiler
Mostly Biotech 🧬 retweetledi

This is unprecedented:
Short positions in Brent crude oil futures by producers, merchants, processors, and commercial users are up to a record $193 billion.
These are the companies that physically produce, refine, trade, and consume oil, from major producers and refineries to shipping firms and industrial users.
Short positions have DOUBLED since the start of the year.
By comparison, the 2022 energy crisis peak was ~$155 billion.
By selling futures contracts at today's prices, producers are agreeing to sell their future oil at ~$100+ per barrel, even if the market price falls by the time they actually pump it.
This guarantees their revenue regardless of where prices go next, protecting their margins when prices normalize.
Oil producers are seeing unprecedented profitability.

English

@WassimLaroussi3 The most important thing is to have a good product.. the rest is just a marketing and sales job which is an easy fix!
Plus, KURAs drug was just approved (end of November)! I would give them 1-2 quarters for marketing.
English

$KURA vs $SNDX
While Kura's drug has more potential to move frontline (based on safety profile) - it's still lagging in "Marketing" and Commercialization.
Prescribers would most likely look (google) for the drug by drug name, while consumers would look for the brand name.
Google Trends
$KURA looking very attractive at current valuation, but they need to change the way they are commercializing their product.


English
Mostly Biotech 🧬 retweetledi
Mostly Biotech 🧬 retweetledi

Mostly Biotech 🧬 retweetledi
Mostly Biotech 🧬 retweetledi

Mostly Biotech 🧬 retweetledi
Mostly Biotech 🧬 retweetledi
Mostly Biotech 🧬 retweetledi
Mostly Biotech 🧬 retweetledi

$PYPL just made Venmo a lot more interesting!
The headline is simple: Venmo users can now send money to PayPal users across 90 markets. But the real move here is bigger than cross-border P2P. It pushes Venmo further away from being just a U.S. social payments app and closer to a global money network.
That matters because PayPal has spent years sitting on one of the strongest consumer payment brands in the world without fully monetizing the asset base. Venmo was always the obvious first-mover advantage, and product moves like this are the closest thing to actually compounding that advantage instead of just talking about it.
From an investor angle, this is the kind of update that can help rebuild the narrative around $PYPL: better engagement, a broader network, and more optionality on monetization if management keeps shipping. It is still early, but the direction is interesting.

English
Mostly Biotech 🧬 retweetledi

🚨 $PYPL expands its stablecoin PYUSD into 70 markets
$CRCL is valued at $32 billion while $PYPL at $40 billion.
That’s really crazy considering PayPal has Venmo, Stablecoin, Braintree, PayPal branded checkout and PayPal Advertising Business encompassing 400 million users !!
And market today is valuing none of those business fully !! And add a 15% buyback yield to it !!

English
Mostly Biotech 🧬 retweetledi

@KobeissiLetter Announcing detailed concessions before Iran confirms anything just weakens your own negotiating position.
English

BREAKING: President Trump says his envoys Steve Witkoff and Jared Kushner have spoken with a senior Iranian official, with potential "deal" terms emerging, per Axios.
President Trump on potential deal terms:
1. Iran committed not to pursue nuclear weapons or to enrich uranium, and to hand over its existing stockpiles
2. Iran agreed to be "low key on the missiles"
3. Iran also agreed to reopen the strait of Hormuz
4. "If they carry through with that it will end the conflict. They want to make a deal. We want to make a deal too. If this happens it is a great start for Iran to build itself back," Trump said
The US notified Israel on Monday about the peace talks with Iran.
We await comment from Iran.
English
Mostly Biotech 🧬 retweetledi
















